AU1156399A - Reduction of chlorophyll content in oil plant seeds - Google Patents
Reduction of chlorophyll content in oil plant seeds Download PDFInfo
- Publication number
- AU1156399A AU1156399A AU11563/99A AU1156399A AU1156399A AU 1156399 A AU1156399 A AU 1156399A AU 11563/99 A AU11563/99 A AU 11563/99A AU 1156399 A AU1156399 A AU 1156399A AU 1156399 A AU1156399 A AU 1156399A
- Authority
- AU
- Australia
- Prior art keywords
- promoter
- plants
- plant
- seeds
- chlorophyll
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229930002875 chlorophyll Natural products 0.000 title claims description 64
- 235000019804 chlorophyll Nutrition 0.000 title claims description 64
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 title claims description 63
- 230000009467 reduction Effects 0.000 title description 13
- 241000196324 Embryophyta Species 0.000 claims description 123
- 238000000034 method Methods 0.000 claims description 38
- 230000015572 biosynthetic process Effects 0.000 claims description 34
- 230000000692 anti-sense effect Effects 0.000 claims description 29
- 238000003786 synthesis reaction Methods 0.000 claims description 25
- 102000004190 Enzymes Human genes 0.000 claims description 21
- 108090000790 Enzymes Proteins 0.000 claims description 21
- 230000009261 transgenic effect Effects 0.000 claims description 21
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 19
- 239000003921 oil Substances 0.000 claims description 18
- 235000019198 oils Nutrition 0.000 claims description 18
- 239000013612 plasmid Substances 0.000 claims description 16
- 238000012546 transfer Methods 0.000 claims description 15
- 239000012634 fragment Substances 0.000 claims description 14
- 150000007523 nucleic acids Chemical group 0.000 claims description 14
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 8
- 239000008158 vegetable oil Substances 0.000 claims description 8
- 108091026890 Coding region Proteins 0.000 claims description 7
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 7
- 229930195712 glutamate Natural products 0.000 claims description 6
- 108010086470 magnesium chelatase Proteins 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 238000011069 regeneration method Methods 0.000 claims description 5
- 241000894007 species Species 0.000 claims description 5
- 238000013518 transcription Methods 0.000 claims description 5
- 230000035897 transcription Effects 0.000 claims description 5
- 108010015514 Glutamate-tRNA ligase Proteins 0.000 claims description 4
- 102000003929 Transaminases Human genes 0.000 claims description 4
- 108090000340 Transaminases Proteins 0.000 claims description 4
- 230000008929 regeneration Effects 0.000 claims description 4
- 101710168820 2S seed storage albumin protein Proteins 0.000 claims description 3
- 108010023021 Glutamyl-tRNA reductase Proteins 0.000 claims description 3
- 239000013604 expression vector Substances 0.000 claims description 3
- 230000010354 integration Effects 0.000 claims description 3
- 241000219193 Brassicaceae Species 0.000 claims description 2
- 101710094902 Legumin Proteins 0.000 claims description 2
- 101710202365 Napin Proteins 0.000 claims description 2
- 108091036407 Polyadenylation Proteins 0.000 claims description 2
- NEKNNCABDXGBEN-UHFFFAOYSA-L disodium;4-(4-chloro-2-methylphenoxy)butanoate;4-(2,4-dichlorophenoxy)butanoate Chemical group [Na+].[Na+].CC1=CC(Cl)=CC=C1OCCCC([O-])=O.[O-]C(=O)CCCOC1=CC=C(Cl)C=C1Cl NEKNNCABDXGBEN-UHFFFAOYSA-L 0.000 claims description 2
- 102000001861 Glutamyl-tRNA synthetases Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 description 50
- 210000004027 cell Anatomy 0.000 description 46
- 239000013598 vector Substances 0.000 description 24
- 108020004414 DNA Proteins 0.000 description 19
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 17
- 229960002749 aminolevulinic acid Drugs 0.000 description 17
- 240000002791 Brassica napus Species 0.000 description 15
- 239000002609 medium Substances 0.000 description 15
- 230000009466 transformation Effects 0.000 description 15
- 235000011293 Brassica napus Nutrition 0.000 description 12
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 11
- 239000002299 complementary DNA Substances 0.000 description 10
- 108010057891 Glutamate-1-semialdehyde 2,1-aminomutase Proteins 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000006870 ms-medium Substances 0.000 description 9
- 229930027917 kanamycin Natural products 0.000 description 8
- 229960000318 kanamycin Drugs 0.000 description 8
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 8
- 229930182823 kanamycin A Natural products 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- MPUUQNGXJSEWTF-BYPYZUCNSA-N (S)-4-amino-5-oxopentanoic acid Chemical compound O=C[C@@H]([NH3+])CCC([O-])=O MPUUQNGXJSEWTF-BYPYZUCNSA-N 0.000 description 7
- 229920000936 Agarose Polymers 0.000 description 7
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 7
- 235000019484 Rapeseed oil Nutrition 0.000 description 7
- 239000003550 marker Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 108020004707 nucleic acids Proteins 0.000 description 7
- 102000039446 nucleic acids Human genes 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 210000001938 protoplast Anatomy 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 6
- 229960003669 carbenicillin Drugs 0.000 description 6
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 5
- 108020005544 Antisense RNA Proteins 0.000 description 5
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 5
- 241000208125 Nicotiana Species 0.000 description 5
- 238000010353 genetic engineering Methods 0.000 description 5
- 238000003306 harvesting Methods 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 5
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000003184 complementary RNA Substances 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 230000005070 ripening Effects 0.000 description 4
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 3
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 3
- JOOXCMJARBKPKM-UHFFFAOYSA-N 4-oxopentanoic acid Chemical compound CC(=O)CCC(O)=O JOOXCMJARBKPKM-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241000589158 Agrobacterium Species 0.000 description 3
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 description 3
- 102000001888 Glutamate-tRNA ligase Human genes 0.000 description 3
- 206010020649 Hyperkeratosis Diseases 0.000 description 3
- 238000000636 Northern blotting Methods 0.000 description 3
- 108091034057 RNA (poly(A)) Proteins 0.000 description 3
- 238000002105 Southern blotting Methods 0.000 description 3
- 239000001752 chlorophylls and chlorophyllins Substances 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000010348 incorporation Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 230000037353 metabolic pathway Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 229950003776 protoporphyrin Drugs 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical class CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 2
- -1 C22 fatty acids Chemical class 0.000 description 2
- WDFJYRZCZIUBPR-UHFFFAOYSA-N Hydroxymethylbilane Natural products OC(=O)CC1=C(CO)NC(CC2=C(C(CCC(O)=O)=C(CC3=C(C(CCC(O)=O)=C(CC4=C(C(CCC(O)=O)=CN4)CC(O)=O)N3)CC(O)=O)N2)CC(O)=O)=C1CCC(O)=O WDFJYRZCZIUBPR-UHFFFAOYSA-N 0.000 description 2
- 239000007836 KH2PO4 Substances 0.000 description 2
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 108010060806 Photosystem II Protein Complex Proteins 0.000 description 2
- 108020004566 Transfer RNA Proteins 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 239000003139 biocide Substances 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- 238000010170 biological method Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229930002868 chlorophyll a Natural products 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 125000000291 glutamic acid group Chemical group N[C@@H](CCC(O)=O)C(=O)* 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- VONNLLSMCGYFIZ-UHFFFAOYSA-N hydroxymethylbilane Chemical compound OC(=O)C[C]1C(CO)=NC(CC=2[C](C(CCC(O)=O)=C(CC=3[C](C(CCC(O)=O)=C(CC=4[C](C(CCC(O)=O)=CN=4)CC(O)=O)N=3)CC(O)=O)N=2)CC(O)=O)=C1CCC(O)=O VONNLLSMCGYFIZ-UHFFFAOYSA-N 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 2
- 229960001669 kinetin Drugs 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 210000002706 plastid Anatomy 0.000 description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000011426 transformation method Methods 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- HXKWSTRRCHTUEC-UHFFFAOYSA-N 2,4-Dichlorophenoxyaceticacid Chemical compound OC(=O)C(Cl)OC1=CC=C(Cl)C=C1 HXKWSTRRCHTUEC-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- 240000008100 Brassica rapa Species 0.000 description 1
- 235000011292 Brassica rapa Nutrition 0.000 description 1
- 101100327819 Caenorhabditis elegans chl-1 gene Proteins 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000005562 Glyphosate Substances 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 102000004867 Hydro-Lyases Human genes 0.000 description 1
- 108090001042 Hydro-Lyases Proteins 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- QSHWIQZFGQKFMA-UHFFFAOYSA-N Porphobilinogen Natural products NCC=1NC=C(CCC(O)=O)C=1CC(O)=O QSHWIQZFGQKFMA-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 238000002123 RNA extraction Methods 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 239000003225 biodiesel Substances 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229930002869 chlorophyll b Natural products 0.000 description 1
- NSMUHPMZFPKNMZ-VBYMZDBQSA-M chlorophyll b Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C=O)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 NSMUHPMZFPKNMZ-VBYMZDBQSA-M 0.000 description 1
- 108091000085 chlorophyll binding Proteins 0.000 description 1
- 108010081694 chlorophyll synthetase Proteins 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- NIUVHXTXUXOFEB-UHFFFAOYSA-N coproporphyrinogen III Chemical compound C1C(=C(C=2C)CCC(O)=O)NC=2CC(=C(C=2C)CCC(O)=O)NC=2CC(N2)=C(CCC(O)=O)C(C)=C2CC2=C(C)C(CCC(O)=O)=C1N2 NIUVHXTXUXOFEB-UHFFFAOYSA-N 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000012877 elongation medium Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000002306 glutamic acid derivatives Chemical class 0.000 description 1
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 1
- 229940097068 glyphosate Drugs 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 229940040102 levulinic acid Drugs 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- BOTWFXYSPFMFNR-PYDDKJGSSA-N phytol Chemical group CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO BOTWFXYSPFMFNR-PYDDKJGSSA-N 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- YPHQRHBJEUDWJW-UHFFFAOYSA-N porphobilinogen Chemical compound NCC1=NC=C(CCC(O)=O)[C]1CC(O)=O YPHQRHBJEUDWJW-UHFFFAOYSA-N 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- UHSGPDMIQQYNAX-UHFFFAOYSA-L protoporphyrinogen(2-) Chemical compound C1C(=C(C=2C=C)C)NC=2CC(=C(C=2CCC([O-])=O)C)NC=2CC(N2)=C(CCC([O-])=O)C(C)=C2CC2=C(C)C(C=C)=C1N2 UHSGPDMIQQYNAX-UHFFFAOYSA-L 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000037343 tetrapyrrole metabolism Effects 0.000 description 1
- UZKQTCBAMSWPJD-UQCOIBPSSA-N trans-Zeatin Natural products OCC(/C)=C\CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-UQCOIBPSSA-N 0.000 description 1
- UZKQTCBAMSWPJD-FARCUNLSSA-N trans-zeatin Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-FARCUNLSSA-N 0.000 description 1
- HUHWZXWWOFSFKF-UHFFFAOYSA-N uroporphyrinogen-III Chemical compound C1C(=C(C=2CCC(O)=O)CC(O)=O)NC=2CC(=C(C=2CCC(O)=O)CC(O)=O)NC=2CC(N2)=C(CC(O)=O)C(CCC(=O)O)=C2CC2=C(CCC(O)=O)C(CC(O)=O)=C1N2 HUHWZXWWOFSFKF-UHFFFAOYSA-N 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940023877 zeatin Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Nutrition Science (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
1 Reduction of Chlorophyll Content in Oil Plant Seeds This invention concerns methods for reducing the chlorophyll content the seeds of oil plants, in particular rapeseed, based on the expression of chlorophyll synthesis antisense genes. In addition, the method concems seeds of oil plants that have reduced chlorophyll content compared to the wild 5 types, as well as the use of these seeds to produce vegetable oils. Next to soy and cottonseeds, the crucifers rape (Brassica napus) and turnip (Brassica rapa) are among the most important oil plants. The seeds of the rape plant contain about 40% fatty oil, the so called rapeseed oil or turnipseed oil, which as a rule is obtained from the crushed seeds by pressing or extraction in a yield of about 40% and then is refined. The rapeseed oil that is obtained can then be 10 used as food oil, mineral lubricant oil additive, for production of margarine after hydrogenation, and as raw material in the production of grafting wax, plasters, leather dressings, and so forth. Rapeseed oil is also known as a good source for, among other things, C 20 and C22 fatty acids, which are important as agents in plastics processing and detergents. In addition to their use as industrial raw materials, vegetable oils, especially rapeseed oil, are becoming increasingly important as biodiesel fuels. 15 Generally speaking, the ranges of use of vegetable oils have become considerably broader in recent years. With rising environmental awareness, environmentally compatible industrial products, for example, lubricants and hydraulic fluids, have increasingly been developed. The problem of high chlorophyll levels in rapeseeds is generally known, especially in rape cultivation with short growing seasons. With every harvest growers and seed concerns must weigh the 20 risk of losing the harvest to frost against the additionally necessary ripening of the seeds, during which, moreover, decomposition of pigments occurs. For this reason rape is frequently allowed to lie for several days after harvesting for further ripening before the harvest is brought in. A further complication is that low temperatures, frost temperatures that are sublethal for the seeds promote chlorophyll biosynthesis in rapeseeds and thus additionally counteract the 25 decomposition of pigments that takes place during ripening, due to which undesirably high chlorophyll levels in rapeseeds can occur in particular in areas of cultivation with relatively short growing seasons. In refining the rapeseed oil the pigments, especially the chlorophylls contained in the seeds and their photosensitive precursors, must be extracted at high cost. Apart from the fact that these extractions are costly from the standpoint of time and money, they also always mean a loss of the 30 rapeseed oil yield. Although turnips make somewhat lesser demands than rape with regard to growing time and location, these Brassicaceae have similar problems with regard to the ripening of the seeds and excess chlorophyll content. The recovery and use of turnipseed oil largely correspond to those of rapeseed oil. Chlorophyll synthesis in rape and turnip plants and their seeds could be affected by means of 35 molecular biotechnology to the extent that the amount of excess chlorophyll in the rapeseeds could be reduced or completely chlorophyll-free seeds could be produced. Tetrapyrrole biosynthesis, which in plants takes place chiefly in plastids, progresses, as is currently assumed, according to the following metabolic pathway (see also in this regard Figure 1). 5 Aminolevulinic acid (ALA) is produced from glutamate via three enzyme activities (glutamyl tRNA 40 synthetase, glutamyl tRNA reductase and glutamate 1-semialdehyde aminotransferase). Two ALA 2 molecules condense to a cyclic compound, porphobilinogen, which is converted to the first tetrapyrrole, hydroxymethylbilane by concatenation of 4 units. Protoporphyrin IX results from hydroxymethylbilane through oxidations and side chain modifications via uroporphyrinogen 111, coproporphyrinogen and protoporphyrinogen IX. Incorporation of a bivalent metal cation results in 5 magnesium protoporphyrin IX, which converts to chlorophyll a through additional modifications, which involve, among other things, the incorporation of an additional isocyclic ring on ring B and the particularly important esterification of a propionate with a phytol chain. The knowledge of plant genes that code for enzymes of the above indicated chlorophyll synthesis path and the possibility of transferring such genes in a targeted way to plants is an 10 important basis of this invention. European Patent Application No. 0 779 364 A2 describes an approach to reducing the chlorophyll content in transgenic plants, in which the transcript and protein content of the. chlorophyll binding proteins (chlorophyll a/b binding (CAB) proteins) of the aerial complex of the photosystem 1| (light harvesting complex associated with photosystem II, LHCII) is reduced. This approach, which is 15 based on the expression of antisense genes for LHCII thus concerns proteins that already bind synthesised chlorophyll in photosystem II, but not enzymes that are directly involved in chlorophyll synthesis. In addition, experimental data from Flachmann and KOhlbrandt (Plant Cell (1995)7, 149-160) indicate that as a consequence of the expression of antisense genes for LHCII the RNA contents in 20 the leaves of transgenic tobacco plants are reduced by up to 5% of the control values in wild types, but neither a reduction of the LHC protein content nor a chlorophyll reduction is observed. Flachmann and KOhlbrandt were unable to establish a correlation between the decrease of the LHC-RNA level and the reduction of the protein and chlorophyll content. In contrast to the strategy pursued in the prior art, it ought to be possible to achieve a 25 successful and reliable reduction of the chlorophyll content in transgenic plants by means of direct intervention in the tetrapyrrole synthesis. Therefore, a task of this invention is to point out ways by which chlorophyll synthesis in transgenic oil plant seeds can be reduced or blocked and in this way the chlorophyll content reduced by means of genetic engineering methods. 30 In addition, an important task of the invention is to make available transgenic oil seeds with chlorophyll content that is lower than that of seeds from wild species of plants. Other tasks of the invention arise from the following description. These tasks are solved through the objects of the independent claims, in particular on the basis of making available of the methods for reduction of the chlorine content in plant seeds in accordance with the invention as well 35 as the plants and parts and products of plants with chlorophyll content reduced compared to wild species of plants in accordance with the invention. This invention thus concerns the use of DNA sequences that code for chlorophyll synthesis enzymes and whose targeted transfer to and expression in transgenic plant cells result in a reduction of chlorophyll synthesis. More precisely, the invention concerns the transfer of suitable antisense gene 40 constructs to plants and their expression in the plant tissue.
3 The invention is based on experiments in which it was possible to reduce significantly the amount of chlorophyll in plant seeds by the seed-specific expression of antisense genes to certain enzyme steps of tetrapyrrole synthesis and the resulting seed-specific inhibition of the activity of specific enzymes of chlorophyll synthesis. 5 The antisense technique employs the complementarity of nucleic acid molecules in an elegant way. Antisense genes that code for tetrapyrrole metabolism enzymes complementarily to endogenous RNA reduce the endogenous RNA contents or the number of RNA molecules available for subsequent protein biosynthesis. A reduced content of endogenous RNA necessarily results in reduced translation, and thus a reduced amount of protein, which again is expressed in a reduced 10 activity of the target enzyme. The invention concerns all genes whose gene products catalyse steps of tetrapyrrole synthesis. Since the expression and activity of any enzyme involved in tetrapyrrole synthesis can be reduced or inhibited by targeted antisense RNA synthesis, the method for reducing the chlorophyll content of seed cells uses all of the genes of this metabolic pathway, ie., individually or in combination. These 15 genes are above all genes that code for glutamyl tRNA synthetase, glutamyl tRNA reductase, glutamate 1-semialdehyde aminotransferase, magnesium chelatase or its subunits CHL 1, CHL D, CHL H, chlorophyll synthetase and Mg protoporphyrin monomethyl ester transferase. The invention also concerns fragments of genes that are involved in chlorophyll synthesis and whose use within an antisense construct results in reduced activity of the target enzyme. Such 20 fragments could in connection with this invention be called. "antisense-active" fragments, ie., their transfer in the form of a suitable construct brings about a reduction of the corresponding endogenous enzyme activity. In addition, the invention concerns the use of alleles and derivatives of the genes in accordance with the invention to reduce the chlorophyll content of plant seeds, thus the use of nucleic acid 25 molecules whose sequences, due to degeneration of the genetic code, differ from the genes in accordance with the invention and whose transfer to plant cells results in a reduction of the content of the desired enzyme of chlorophyll metabolism caused by the antisense gene. In addition, the invention concerns the use in accordance with the invention of nucleic acid molecules that contain the antisense genes in accordance with the invention or that result from them 30 by naturally occurring or by genetic engineering or chemical processes and synthesis methods or derived from them. These can be, for example, DNA or RNA molecules, cDNA, genomic DNA, mRNA, etc. The following genes of chlorophyll synthesis are preferably used for reduction of the chlorophyll content of seed tissue within the scope of the invention. 35 Genes that code for glutamate 1-semialdehyde aminotransferase (GSA-AT). This enzyme catalyses the conversion of glutamate 1-semialdehyde (GSA) to aminolevuliic acid (ALA) through the net transfer of an amino group from C2 to C1. The expression of a tobacco antisense RNA for GSA AT up to now has been investigated only in the leaves of tobacco plants (H6fgen et al. (1994) Proc. Natl. Acad. Sci. USA 91, 1726-1730). DNA sequences of two tobacco full length cDNA clones are 40 available in the Gene Bank, Accession Nos. X65973 and X65974.
4 Genes that code for the subunits CHL I and CHL H of magnesium chelatase. The subunits of Mg chelatase are involved in the incorporation of magnesium into protoporphyrin IX. Suitable DNA sequences of full length cDNA clones that code for CHL I and CHL H are described in Kruse et al. (1997) Plant Mol. Biol. 35, 1053-1056 and under accession Nos. AF014053 (Chi I) orAFOl4051 and 5 AF14052 (ChlH) in the gene bank. Genes that code for the plastid glutamyl tRNA synthetase. This enzyme catalyses the formation of glutamyl tRNA from glutamic acid. Genes that code for glutamyl tRNA reductase. This enzyme catalyses the reduction of activated glutamate to glutamate 1-semialdehyde. Suitable DNA sequences of full length cDNA clones from a 1o barley cDNA bank that code for the reductase are described in Bougri and Grimm (1996) Plant J. 9, 7867-878 and under Accession Nos. X86101, X86102 and X92403 in the gene bank. In an antisense gene construct in accordance with the invention a gene of chlorophyll synthesis or a fragment thereof, preferably the coding region of such a gene or a fragment, is bonded in antisense orientation, ie., 3' -> 5' orientation, with the 3' end of a promoter, thus a regulator element 16 that guarantees the transcription of the coupled gene into plant cells. The genes in accordance with the invention can be expressed in plant cells, for example, under control of constitutive, but also inducible or tissue- or development-specific promoters. These are pref rably seed-specific promoters whose use enables the targeted inhibition of chlorophyll synthesis in s< ed cells. 20 Examples of seed-specific promoters that can be used in connection with the invention that may be mentioned are the USP promoter (described, among other places, in: Baumlein et a. (1991) Mol. Gen. Genet. 459-467; Fiedler et al. (1993) Plant Mol. Biol. 22, 669-679; DE-C2-39 20 034), the napi promoter (Ericson et al. (1991) Eur. J. Biochem. 197, 741-746; Accession No. X 58142), the 2S albumin promoter (Krebbers et al. (1988) Plant Physiol. 87, 859-866; Accession No. Z 24745), the 25 legu nin promoter (Bsumlein et al. (11986) Nucl. Acids Res. 14, 2707-2720; Accession No. X 03677) and the hordeine promoter (Entwistle et al. (1991) Plant Mol. Biol. 17, 1217-1231; Accession No. X6037). Optionally, the antisense constructs used in accordance with the invention can additionally incl e enhancer sequences or other regulator sequences. 30 It is likewise a task of the invention to make available new plants, plant cells, plant parts or plant products that are characterised by a reduced chlorophyll content compared to the wild species. These tasks are solved through the transfer of the antisense nucleic acid molecules in accordance with the invention and their expression in plants. The making available of the nucleic acid molecules in accordance with the invention now presents the possibility of altering plant cells by 35 means of genetic engineering methods to the extent that they have a reduced chlorophyll biosynthesis power compared to wild types. In accordance with the invention these are seeds of oil plants, especially rape and turnip, that have significantly reduced chlorophyll content compared to seeds of the wild species. The transgenic rape plants are especially preferably spring rape plants. Likewise 00 rape plants, ie., rape plants that are erucic acid-free and low-glucosinolate, are also suitable for use of 40 the methods in accordance with the invention.
5 The plants that are transformed with the nucleic acid molecules in accordance with the invention and in which a lower amount of chlorophyll is synthesised because of the integration of such a molecule into their genome can in principle be any plants. Preferably, these are oil plants like rape and turnip from which a vegetable oil is obtained and in the recovery of which high chlorophyll 5 contents are undesirable. An object of the invention is in particular propagation material of plants in accordance with the invention, for example, seeds, fruits, cuttings, bulbs, root stock, etc., where this propagation material optionally contains the above described transgenic plant cells, as well as parts of these plants like protoplasts, plant cells and calli; especially preferably these are seeds. 10 This invention additionally has the task of making available methods for producing plant cells and plants and parts thereof, especially seeds, that are characterised by a reduced chlorophyll content. This task is solved by methods with which the generation of new plant cells and plants that are characterised by a reduced chlorophyll content compared to the wild types due to the transfer and 15 expression of antisense genes that are directed toward endogenous genes that code for the enzymes of chlorophyll synthesis is possible. There are various genetic engineering transformation methods for generation of such new plant cells and plants. In accordance with the invention, plant cells that are characterised by a reduced chlorophyll content due to the expression of an antisense: gene construct in accordance with the 20 invention are produced by a method that includes the following steps: a) Preparation of an expression cassette, which includes the following DNA sequences: -a promoter that ensures transcription into plant cells; - at least one nucleic acid sequence that codes for an enzyme or a fragment thereof that participates in chlorophyll synthesis, where the nucleic acid sequence is coupled in antisense orientation to the 3' 25 end of the promoter, and - optionally a termination signal for termination of transcription and addition of a poly (A) tail to the corresponding transcript that is coupled to the 5' end of the nucleic acid sequence. b) Transformation of plant cells with the expression cassette prepared in step (a). c) Regeneration of transgenic plants and optionally propagation of the plants. 30 Furthermore, the invention concerns the use of the antisense constructions in accordance with the invention to generate plants, especially plant seeds, that have a reduced chlorophyll content. Preferably the invention concerns the use of the antisense constructions in accordance with the invention to generate seeds of oil plants, especially rape and turnip, that have a reduced chlorophyll content. 35 Another task of the invention is to point out the possibilities of using the plants in accordance with the invention or their cells, parts and products, especially their seeds. An object of the invention is in particular the use of the plants in accordance with the invention, especially their seeds, to obtain vegetable oils as raw materials for the chemical, cosmetics, pharmaceuticals and food industry and as energy carriers.
6 The plants in accordance with the invention thus represent an important source for obtaining vegetable oils, especially rapeseed and tumipseed oil, for a broad spectrum of commercial purposes. Possibilities for said promoter are in principle any of the functional promoters in the plants chosen for transformation that satisfy the requirement that the expression that they regulate leads to a 5 reduced chlorophyll synthesis power in plant cells. In view of the use of the transgenic plants as providers of vegetable oils promoters that ensure seed-specific expression appear to be particularly meaningful here. Examples of such promoters are the USP, napin, 2S albumin, legumin and hordeine promoters mentioned above. If such promoters are not known or are not available, in any case the concept of isolating such 10 promoters is well known to the specialist. Here poly(A)+ RNA is isolated from seed tissue and a cDNA bank is set up in a first step. In a second step cDNA clones that are based on poly(A)+ RNA molecules from tissue not deriving from the seeds from the first bank are used to identify by means of hybridisation those clones whose corresponding poly(A)+ RNA molecules are expressed only in the plant tissue. Then the cDNAs identified in this way are used to isolate promoters that then can be 15 used for antisense expression. A large number of cloning vectors that contain a replication signal for E coli and a marker gene for selection of transformed bacterial cells is available for preparation for the insertion of foreign genes into higher plants. Examples of such vectors are pBR322, the pUC series, M13mp series, pACYC 184, and so forth. The desired sequence can be introduced at a convenient restriction cut site in the vector. 20 The resulting plasmid is used for transformation of E coli cells. The transformed E coli cells are grown in a suitable medium and then harvested and lysed. The plasmid is recovered. In general restriction analyses, gel electrophoreses and other biochemical/molecular biological methods are used as analysis methods to characterise the resulting plasmid DNA. After each manipulation the plasmid DNA can be split and the recovered DNA fragments can be bonded to other DNA sequences. 25 Each plasmid DNA sequence can be cloned in the same or other plasmids. A larger number of known techniques are available for introduction of DNA into a plant host cell, and the specialist can easily determine the method that is suitable in each case. These techniques include the transformation of plant cells with T-DNA using Agrobacterium tumefaciens or Agrobacterium rhizogenes as transformation agents, fusion of protoplasts, direct gene transfer of 30 isolated DNA in protoplasts, electroporation of DNA, the insertion of DNA by means of biolistic methods as well as other possibilities. In the injection and electroporation of DNA in plant cells no special requirements per se are made on the plasmids that are used. This is also true for direct gene transfer. Simple plasmids like pUC derivatives can be used. However, if whole plants are to be regenerated from the cells that are 35 transformed in this way, the presence of a selectable marker gene is necessary. The common selection markers are known to the specialist and selecting a suitable marker will not be problem. Additional DNA sequences may be necessary, in each case according to the method of insertion of desired genes into the plant cell. If, for example, Ti or Ri plasmid is used for transformation of the plant cell, then at least the right boundary, and frequently the right and left boundary, of the T- 7 DNA contained in the Ti and Ri plasmid must be bonded to the genes to be introduced as a flanking region. If agrobacteria are used for the transformation, the DNA to be introduced must be cloned in special plasmids, namely either in an intermediary or a binary vector. The intermediary vectors can be 5 integrated into the Ti or Ri plasmid of the agrobacteria by homologous recombination by means of sequences that are homologous to sequences in the T-DNA. The plasma additionally contains the vir region necessary for transfer of the T-DNA. Intermediate vectors cannot replicate in agrobacteria. Using a helper plasmid, the intermediary vector can be transferred to Agrobacterium tumefaciens (conjugation). Binary vectors can replicate both in E. coli and in agrobacteria. They contain a selection 10 marker gene and a linker or polylinker which are framed by the right and left T-DNA boundary region. They can be transformed directly to the agrobacteria (Holsters et al. (1978) Molecular and General Genetics 163, 181-187). The agrobacterium that serves as host cell should contain a plasmid that carries a vir region. The vir region is necessary for transfer of the T-DNA to the plant cells. Additional T-DNA can be present. The agrobacterium transformed in this way is used for transformation of plant 15 cells. The use of T-DNA for transformation of plant cells has been intensively investigated and described extensively in EP 120 515; Hoekema in: the Binary Plant Vector System, Offsetdrokkerij Kanters B.V., Alblasserdam (1985) Chapter V; Fraley et al. (1993) Crit. Rev. Plant. Sci., 4, 1-46 and An et al. (1985) EMIBO J. 4, 277-3 87. 20 For the transfer of the DNA into the plant cells plant, explants can be cultured expediently with Agrobacterium tumefaciens or Agrobacterium rhizogenes. Then from the infected plant material (for example, leaf pieces, stem segments, roots, as well as protoplasts or suspension-cultured plant cells) whole plants can be regenerated in a suitable medium, which can contain antibiotics or biocides for selection of transformed cells. The regeneration of the plants takes place by conventional 25 regeneration methods using known nutrient media. The plants obtained in this way can then be tested for presence of the introduced DNA. Other possibilities for the introduction of foreign DNA using the biolistic method or by protoplast transformation are well known (see, for example, Willmitzer L. (1993) Transgenic Plants, in: Biotechnology, A Multi-volume Comprehensive Treatise (H.J. Rehm. G. Reed, A. Pilhler, P. Stadler, eds.) Vol. 2, 627-659, V.C.H. Weinheim - New York - Basel - Cambridge). 30 Once the introduced DNA is integrated into the genome of the plant cell, as a rule it is stable there and continues to remain in the descendants of the original transformed cell. It normally contains a selection marker that confers resistance to a biocide or antibiotic like kanamycin, G418, bleomycin, hygromycin, methotrexate, glyphosate, streptomycin, sulfonylurea, gentamycin or phosphinotricin, etc., to the transformed plant cells. The individually selected marker should then allow the selection of 35 the transformed cells compared to cells that lack the introduced DNA. The transformed cells grow within the plant in the usual way (see also McCormick et al. (1986) Plant Cell Reports 5, 81-84). The resulting plants can be grown in the normal way and crossed with plants that have the same transformed genetic makeup or another genetic makeup. The resulting hybrid individuals have the corresponding phenotypic properties. Seeds can be obtained from the 40 plants.
8 Two or more generations should be grown in order to guarantee that the phenotypic trait will continue to remain stable and be inherited. In addition, seeds should be harvested in order to guarantee that the corresponding phenotype or other characteristics have remained preserved. Likewise, conventional methods can be used to determine transgenic lines that are 5 homozygous for the new nucleic acid molecules and their phenotypic behaviour with respect to altered chlorophyll content tested and compared with that of hemizygous lines. The transfer and expression of the antisense gene constructs in accordance with the invention can take place with the aid of traditional molecular biological and biochemical methods. These techniques are known to the specialist and he is capable of easily selecting a suitable detection 10 method, for example, a Northern blot analysis, for qualitative and quantitative detection of RNA that is specific for the coding region of the relevant antisense gene, or a Southern blot analysis for identification of the transferred DNA sequences. The resulting transgenic plant cells or plants as well as parts and products thereof can then be tested for their chlorophyll content. The following analysis methods, for example, suggest themselves 16 on this regard: - Determination of the chlorophyll and carotinoid contents after Porra et al. (1989) Biochem. Biophys. Acta 975, 384-394; - determination of ALA synthesis power (as described, for example, in Zavgorodnyaya et al. (1997) The Plant J. 12, 169-178); 20 - determination of the glutamate 1-semialdehyde aminotransferase activity (see also Zavgorodnyaya et al. (1997) supra). Often a reduced chlorophyll content in transgenic plants or their parts and products compared to the wild types can be detected with the naked eye or with optical aids. Common methods such as are described in the relative laboratory manuals like Sambrook et al. 25 (1989) Molecular Cloning: A Laboratory Manual, 2nd edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, can be used for DNA and RNA isolation, sequence analysis, restriction, cloning, gel electrophoresis, radioactive labelling, Southern, Northern and Western blot analyses, hybridisation and the like. The following examples serve to illustrate the invention. 30 Examples Example I Preparation of an antisense construct based on DNA sequences that code for a glutamate 1-semialdehyde aminotransferase from tobacco For construction of a GSA-AT antisense mRNA expression vector the complete 1714bp 35 tobacco GSa-AT-cDNA fragment (Gene Bank Accession No. X65974; see H6fgen et al., supra) as EcoRV/Xbal restriction fragment was cloned into the binary vector BinHyg-Tx, a plasmid derivative of the vector BinAR (H6fgen and Willmitzer (1990) Plant Sci. 66, 221-230), which was cut beforehand with the restriction enzymes Smal and Xbal. For preparation of a binary vector with a fusion of an USP promoter and the GSA-AT-cDNA 40 sequence in antisense orientation the vector pP30T containing the USP promoter from Vicea faba, a pUC18 derivative (see also Baumlein et al. (1991), supra) was cut with Pstl and BgIll. The isolated 9 USP promoter fragment was then cloned in a BamHl/PstI-cut pBluescript vector (-> pUSPblue). This vector construct pUSPblue was then cut with EcoRI and Xbal in order to obtain an EcoRI/Xbal promoter fragment. The 35S CaMV promoter was removed from the binary vector BinAR by restriction digestion with EcoRi and Xbal and, by ligation of the EcoRI/Xbal vector fragment with the USP 5 promoter fragment replaced by this seed-specific promoter (-* pUSPbin). The complete cDNA sequence (Xbal-3'-GSA-AT-cDNA-5'-Sall) cut from the pBluescript with Xbal and Sall was then inserted in the Xbal-Sall-cut pUSPbin of tobacco GSA aminotransferase. The resulting binary vector was characterised as pUSPASGSAT (sec also Figure 2). In place of the said binary vectors BinAR or BinHyg-Tx, which contain a tetracycline-inducible 10 CaMV 35S promoter, any suitable vector for plant transformation can be used to prepare an antisense gene consisting of a fusion of a promoter, preferably a seed-specific promoter that guarantees transcription and translation in plant cells, and DNA sequences that code for enzymes that participate in chlorophyll synthesis. Example 2: 15 Transformation of rape plants and regeneration of intact plants The transformation in summer rape was carried out by the method of De Block et al. (1989, Plant Physiol. 91, 694-701) and Damgaard et al. (1997, Transgenic Research 6, 279-288). For this a recombinant culture of Agrobacterium tumefaciens (strain GV 3101) was washed and resuspended in medium 1 (MS medium (Murashige and Skoog (1962) Physiol. Plant 15, 473), 2.5mM 20 MES, pH5.5, 1mg/L benzylaminopurine (BAP), 0.1mg/L napthylacetic acid (NAA), 0.01mg/L gibberellic acid (GA 3 ), and 200pM acetosyringone). The hypocotyl of 14 day old Brassica napus seedlings were cut into segments of 0.5 to 1cm long, incubated for 30 min with the bacterial suspension and then kept for 5 days in the dark at 210C in 0.7% agar containing medium 1. For callus induction the hypocotyl was incubated at 250C on 25 medium 2 (MS medium, 2.5mM MES, pH5.7, 30g/L sucrose, 1mg/L kinetin, 1mg/L 2,4 dichlorophenoxyacetic acid (2,4-D), 0.01mg/L GA 3 , 500mg/L polyvinylpyrrolidone (PVP), 5mg/L AgNO3, 5g/L agarose, 250mg/L carbenicillin, 100mg/L kanamycin; at 150.M photon/m 2 /sec). Formation of the callus was followed by induction of shoots on medium 3 (MS medium, 2.5mM MES, pH5.5, 20g/L sucrose, 40mg/L adenine, 1mg/L IBAP, 0.1mg/L NAA, 0.01mg/L GA 3 , 500mg/L 30 PVP, 5mg/L AgNO3, 100mg/L kanamycin, 5g/L agarose, 250mg/L carbenicillin). After shoot formation has occurred, the calli, which show shoots are transferred to a shoot elongation medium (medium 4) in glass vessels (MS medium, 2.5mM MES, pH5.7, 10g/L sucrose, 0.0025mg/L BAP, 100mg/L kanamycin, 7g/L agarose, 250mg/L carbenicillin). After 2-3 weeks the shoots were transferred to medium 5 (MS medium, 2.5mM MES, pH5.5, 35 7g/L agarose) in order to form roots. Alternatively, rape plants were generated by the following protocol: a recombinant culture of Agrobacterium tumefaciens (strain GV 3101) was washed and resuspended in MS medium with 2.5mM MES, pH5.5. The hypocotyl of 5-7 day old rape seedlings were cut into explants about 7mm long and precultured in liquid CIM medium for 24h. Then the explants were cocultured for 2-3 days in 40 the dark in 50 I. of an overnight culture of the recombinant agrobacterium strain in 1OmL of the CIM 10 medium. The CIM medium consists (per litre) of MS medium, 30g sucrose, 500mg MES, pH5.8, 1mg 2,4-D, 1mg kinetin. Then the hypocotyl pieces were washed and cultured for 7-10 days to callus induction on CIM medium containing 5g/L agarose, 20mg kanamycin, 250mg betabactyl and 250mg carbenicillin. Then the slightly swollen explantates were placed on SIM medium for shoot induction. 5 The medium was replaced every 10-14 days. SIM medium consists (per litre) of MS medium, vitamins, 20g sucrose, 500mg MES, pH5.6-5.8, 2mg zeatin, 2mg BAP, 100mg myoinositol, 5g agarose, 20mg kanamycin, 500mg betabactyl or carbenicillin. After the end of shoot formation, the calli that showed shoots were transferred to glass vessels containing MS medium, 500mg/L MES, pH5.7, 20g/L sucrose, 20mg/L kanamycin, 5g agarose and 500mg/L carbenicillin. 10 In addition to the described transformation methods, rape plants can also be transformed by means of other techniques. For this purpose, the protocol of Moloney et al. (1989, Plant Cell Rep. 8, 23 8-242) suggests itself; in this protocol an agrobacteria-mediated DNA transfer to cotyledons of 7 day-old seedlings takes place via the cut site on the leaf stem. In addition, the transformation of protoplasts using cells of various tissues is suitable (described, for example, in Thomzik (1993) In: 15 Biotechnology in agriculture and forestry, Vol. 23, Plant protoplasts and genetic engineering IV (Bajaj, ed.) Springer-Verlag, Berlin, 170-182). Example 3: Analysis of transgenic plants that express the antisense RNA to glutamate 1-semialdehyde aminotransferase under control of the USP promoter 20 Plants that were transformed with the vector construct pUSPASGSAT (see Example 1 and Figure 2) were then tested for expression of the antisense RNA to GSA-AT. For this purpose the chlorophyll contents and synthesis rates in the transgenic plants were determined. For this chlorophylls were extracted from 100mg plant material ground in liquid nitrogen with buffered, ice-cold 80% acetone until the pellet had become colourless. The samples were 25 appropriately diluted and the extinction measured at 663, 646 and 750nm on a spectrophotometer. The formulas given by Porra et al. (1989, supra) were employed for the calculation of the chlorophyll contents. To determine chlorophyll synthesis rates, seed tissue was incubated in 20mM K 2
HPO
4
/KH
2 PO4 (pH7.1) with 34kBq D-[4- 1 4 C]-labelled ALA (5-aminolevulinic acid) for 8h in light, then a chlorophyll 30 extraction was carried out and separation was done via HPLC. The extraction and separation followed the technique of Gilmore and Yamamoto (1991, J. Chromatography 543, 137-145), modified by Kurse et al. (1995, EMBO J. 14, 3712-3720), as follows: 100mg seed material ground in liquid nitrogen was weighed and extracted with 100% acetone and 10pM KOH until the pellet had become colourless (1 time 400WL, 3 times 200IiL). The extracts were diluted 4:1 with H 2 0 for the HPLC run in order to 35 achieve sharper separations. The chlorophylls were eluted by means of a LiChrospher 100 HPLC RP 18 column (5pi, Merck) at a flow rate of 1mL/min, using the following gradients: 100% eluent A (780mL acetonitrile; 80mL MeOH; 30mL tris/HCI, 0.1M, pH8.0) for 7 min, in a linear increase over 6 min to 100% eluent B (800mL MeOH; 200mL hexane), and 14 min 100% eluent B. The eluate was analysed with a photodiode array (PDA) detector and connected radioactivity monitor. Radioactively 40 labelled chlorophyll could be categorised according to the reaction times, which are known for the HPLC system.
11 In addition, the 5-aminolevulinic acid synthesis capacity in the transgenic plants was determined. Since enzyme activities in the C5 pathway cannot be determined without purifying the enzymes, indirect methods were selected to measure the capacity for ALA formation from glutamate. For one, the accumulation of ALA after incubation o F LA was determined by the following protocol: 5 100-300mg seed tissue per batch was incubated in light for 2-4h with 40mM levulinic acid, a potent inhibitor (substrate similarity) of ALA dehydratase (ALAD), in 20mM K2HP04/KH2PO4 (pH7.1). The plant material was frozen in liquid nitrogen, homogenised and, after adding 1mL 20mM
K
2
HPO
4
/KH
2 PO4 (pH7.1), thoroughly mixed. The ALA determination followed Mauzerall and Granick (1956, 3. Biol. Chem. 219, 435-446). After centrifuging for 20 min at 15 OOg at 4*C, 250[L 20mM 10 K2HP04/KH2PO4 (pH7.1) and 100iL ethyl acetoacetate was pipetted into 250[L of the supernatant. Samples that had been extracted without levulenic acid incubation at time to served as control. All samples were heated for exactly 10 min at 1000C, then cooled on ice for 5 min, thoroughly mixed with 500mL modified Ehrlich's reagent (373mL glacial acetic acid; 9OmL 70% (w/v) perchloric acid; 1.55g HgC2 volume filled to 500mL with H 2 0; 2g p-dimethylaminobenzaldehyde dissolved in 1 10mL of this 15 solution) and centrifuged for 5 min at 15 000g. Extinctions at 525, 553 and 600nm were measured. The nonspecific turbidity, measured at 600nm, was subtracted from all of the values; the ratio
E
5 5 3/E 5 2 5 should lie between 1.3 and 1.5. A reference series was run in order to be able to quantify the ALA contents. In addition, the accumulation of ALA was determined after incubation in glutamate and levulinic 20 acid. For this purpose 100-300mg of seeds are incubated in 92.5kBq L-[U- 1 4 C glutamate, 2mM glutamate, 20mM LA, 880 IL 20mM K 2
HPO
4
/KH
2
PO
4 (pH7.2) for 8h at room temperature in light. The plant material was homogenised in 0.5mL IN TCA and 1% SDS, centrifuged and the supernatant was diluted with 1 volume of eluent (7.8g/L NaH2PO4 1.74g/L SDS, 5mL/L tert-amyl alcohol). The [14C] labelled ALA that formed was detected in accordance with Pontoppidan and Kannangara (1994, Eur. 25 J. Biochem. 225, 529-537) via HPLC (flow rate 1mL/min, isocratic mode; RP 8 column, Novapak C8, 4 pn particle size, 3.9mm x 150mm). The amount of radioactively labelled ALA was determined via an affixed radioactivity monomer. Peak identification was done by Co chromatography with D-[4- 1 4
C]
labelled ALA, and quantification was done by means of reference series of the same substance. In addition, Southern and Northern blot experiments were carried out to detect the integration of 30 the trans genes and the effect on the RNA content for GSA-aminotransferase following standard methods (for example, (Sambrook et al. (1989) supra). The amount of GSA aminotransferase was also determined immunologically in the classic Western Blot analysis, with antibodies being obtained by immunisation of rabbits or mice with Freund's adjuvant. The analysis of transgenic rapeseeds that express the anti sense construct contained in the 35 vector pUSPASGSAT showed that the method in accordance with the invention results in a significant reduction of the chlorophyll content. If the molecular biological operations have not in any way been described sufficiently, they were carried out by standard techniques as described in Sambrook et al. (1989) supra. With regard to the transformation of plants, reference is made to generally known survey articles as well as to the 40 publications mentioned above.
12 Description of Figures: Figure 1 shows the metabolic pathway of tetrapyrrole biosynthesis. Figure 2 shows a restriction map of the binary vector pUSP-ASGSAT described in Example 1, which contains a fusion of the USP promoter and the region coding for GSA aminotransferase in 5 antisense orientation. The vector pUSP-ASGSAT bears a kanamycin resistance gene as the phase selection marker.
Claims (16)
1. A method for reducing the chlorophyll content in seeds of oil plants, which includes the following steps: a) preparation of an antisense expression vector that includes the following DNA sequences: 5 -a promoter that is capable of functioning in plants, in particular a seed specific promoter, - at least one nucleic acid sequence that codes for an enzyme or a fragment thereof that participates in chlorophyll synthesis, where the nucleic acid sequence is linked in antisense orientation to the 3' end of the promoter, and -optionally a termination signal for the termination of transcription and the addition of a poly (A) tail to 10 the corresponding transcript, which is linked to the 5' end of the nucleic acid sequence, b) transfer of the expression vector from (a) to plant cells and integration of the nucleic acid sequence into the plant genome, c) regeneration of transgenic plants and optionally propagation of these plants.
2. A method as in claim 1, where the coding sequence codes for a glutamate 1 15 semialdehyde aminotransferase or at least a part thereof.
3. A method as in claim 1, where the coding sequence codes for the CHL I subunit of magnesium chelatase or at least a part thereof.
4. A method as in claim 1, where the coding sequence codes for the CHL H subunit of magnesium chelatase or at least a part thereof. 20
5. A method as in claim 1, where the coding sequence codes for the plasmid glutamyl tRNA synthetase or at least a part thereof.
6. A method as in claim 1, where the coding sequence codes for a glutamyl tRNA reductase or at least a part thereof.
7. A method as in one of the preceding claims, where the promoter is a USP promoter. 25
8. A method as in one of the preceding claims, where the promoter is a napin promoter.
9. A method as in one of the preceding claims, where the promoter is a 2S-albumin promoter.
10. A method as in one of the preceding claims, where the promoter is a legumin promoter.
11. A method as in one of the preceding claims, where the promoter is a hordeine promoter. 30
12. A method as in one of the preceding claims, where the oil plant belongs to the family of the Brassicaceae.
13. A method as in one of the preceding claims, where the oil plant is rape.
14. A method as in one of claims 1-12, where the oil plant is tumip.
15. Transgenic plant seeds with chlorophyll content reduced by comparison with seeds from 35 wild species, which are obtained from a method as in one of the preceding claims.
16. The use of the seeds as in claim 15 to obtain vegetable oils.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19747739 | 1997-10-29 | ||
DE19747739 | 1997-10-29 | ||
DE19752647A DE19752647C1 (en) | 1997-10-29 | 1997-11-27 | Reduction of the chlorophyll content in oil plant seeds |
DE19752647 | 1997-11-27 | ||
PCT/EP1998/006852 WO1999022011A1 (en) | 1997-10-29 | 1998-10-29 | Reduction of chlorophyll content in oil plant seeds |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1156399A true AU1156399A (en) | 1999-05-17 |
Family
ID=26041176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU11563/99A Abandoned AU1156399A (en) | 1997-10-29 | 1998-10-29 | Reduction of chlorophyll content in oil plant seeds |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1025248A1 (en) |
AU (1) | AU1156399A (en) |
CA (1) | CA2306205A1 (en) |
WO (1) | WO1999022011A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111066437A (en) * | 2019-12-11 | 2020-04-28 | 中国烟草总公司郑州烟草研究院 | Soil conditioning fluid for reducing chloride ion content in tobacco leaves and application method thereof |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6570063B1 (en) | 1999-06-04 | 2003-05-27 | E.I. Dupont De Nemours And Company | Magnesium chelatase |
EP1198578A2 (en) * | 1999-08-03 | 2002-04-24 | Basf Aktiengesellschaft | PLANT S-ADENOSYLMETHIONIN:Mg-PROTOPORPHYRIN-IX-O-METHYLTRANSFERASE, PLANTS WITH VARIABLE CHLOROPHYLL CONTENTS AND/OR HERBICIDE TOLERANCE, AND METHOD FOR THE PRODUCTION THEREOF |
EP2314607A1 (en) * | 2005-12-09 | 2011-04-27 | BASF Plant Science GmbH | Polypeptides involved in regulation of sugar and lipid metabolism and methods of use VIII |
CN118406702A (en) * | 2024-05-16 | 2024-07-30 | 华中农业大学 | Preparation method and application of brassica napus BnaCHL gene and mutant thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5773692A (en) * | 1995-12-12 | 1998-06-30 | Her Majesty The Queen In Right Of Canada, As Represented By Agriculture And Agri-Food Canada | Anti-sense RNA for CAB transcript to reduce chlorophyll content in plants |
-
1998
- 1998-10-29 EP EP98954461A patent/EP1025248A1/en not_active Withdrawn
- 1998-10-29 CA CA002306205A patent/CA2306205A1/en not_active Abandoned
- 1998-10-29 AU AU11563/99A patent/AU1156399A/en not_active Abandoned
- 1998-10-29 WO PCT/EP1998/006852 patent/WO1999022011A1/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111066437A (en) * | 2019-12-11 | 2020-04-28 | 中国烟草总公司郑州烟草研究院 | Soil conditioning fluid for reducing chloride ion content in tobacco leaves and application method thereof |
Also Published As
Publication number | Publication date |
---|---|
WO1999022011A1 (en) | 1999-05-06 |
EP1025248A1 (en) | 2000-08-09 |
CA2306205A1 (en) | 1999-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU756960B2 (en) | Materials and methods for the alteration of enzyme and acetyl CoA levels in plants | |
US7297541B2 (en) | Genes encoding 4-hydroxyphenylpyruvate dioxygenase (HPPD) enzymes for plant metabolic engineering | |
JP2004514401A (en) | Transgenic plants containing tocopherol methyltransferase | |
WO2000010380A1 (en) | Manipulation of tocopherol levels in transgenic plants | |
KR20120007038A (en) | Plant snf1-related protein kinase gene | |
US20040045051A1 (en) | Tocopherol biosynthesis related genes and uses thereof | |
KR100854607B1 (en) | Plant Sterol Acyl Transferase | |
JP2002525034A (en) | DNA sequence encoding 1-deoxy-D-xylulose-5-phosphate synthase and its overproduction in plants | |
US20150322444A1 (en) | Enhanced accumulation of carotenoids in plants | |
US6624342B1 (en) | Manipulation of tocopherol content in transgenic plants | |
US6765129B1 (en) | Overexpression of a DNA sequence coding for a 1-desoxy-d-xylulose-5-phosphate reductoisomerase in plants | |
AU777906B2 (en) | Method of increasing the content of fatty acids in plant seeds | |
AU1156399A (en) | Reduction of chlorophyll content in oil plant seeds | |
US20020128464A1 (en) | Method of finding modulators of enzymes of the carotenoid biosynthetic pathway | |
AU775714B2 (en) | Cloned plant P-hydroxyphenyl pyruvic acid dioxygenase | |
WO2000001828A1 (en) | A modified arabidopsis thaliana cac1, cac2 or cac3 promoter and an arabidopsis thaliana cac1, cac2 or cac3 suppressor element and methods of use thereof | |
CZ20001069A3 (en) | Nucleic acid sequence, alleles and derivatives, nucleic acid molecule, protein, microorganism, transgenic plants, dicotyledonous plants, monocotyledonous plants, transgenic plant cells, method of creating plants, use of plants and use of the nucleic acid sequence | |
MXPA97009724A (en) | Fiber transcription factors of something |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |